Southwestern Internal Medicine Conference: Clinical Features, Pathogenic Mechanisms, and New Developments in the Treatment of Systemic Sclerosis
- 1 March 1990
- journal article
- review article
- Published by Elsevier in The American Journal of the Medical Sciences
- Vol. 299 (3), 193-209
- https://doi.org/10.1097/00000441-199003000-00009
Abstract
No abstract availableKeywords
This publication has 123 references indexed in Scilit:
- Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosisArthritis & Rheumatism, 1988
- Nifedipine in Primary Raynaud's Phenomenon and in Scleroderma: Oral Versus Sublingual Hemodynamic EffectsThe Journal of Clinical Pharmacology, 1987
- Antinuclear antibodies in the relatives and spouses of patients with systemic sclerosis.Annals Of The Rheumatic Diseases, 1986
- Induction of β2-interferon by tumor necrosis factor: A homeostatic mechanism in the control of cell proliferationCell, 1986
- Nifedipine and Thallium-201 Myocardial Perfusion in Progressive Systemic SclerosisNew England Journal of Medicine, 1986
- Prevalence of Raynaud phenomenon in the general populationJournal of Chronic Diseases, 1986
- Transcriptional control of human diploid fibroblast collagen synthesis by γ-interferonBiochemical and Biophysical Research Communications, 1984
- Physiologic Abnormalities of Cardiac Function in Progressive Systemic Sclerosis with Diffuse SclerodermaNew England Journal of Medicine, 1984
- Successful Medical Treatment of Scleroderma Renal CrisisNew England Journal of Medicine, 1978
- Control of Hypertension and Reversal of Renal Failure in SclerodermaNew England Journal of Medicine, 1978